
Results
130
Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.
130 companies
Pfizer
Market Cap: US$158.4b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$28.07
7D
4.8%
1Y
8.5%
Medtronic
Market Cap: US$118.1b
Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
MDT
US$93.35
7D
2.3%
1Y
0.7%
Healwell AI
Market Cap: CA$234.5m
Operates as a healthcare technology company in Canada, Australia, and New Zealand.
AIDX
CA$0.79
7D
5.3%
1Y
-43.2%
Truking Technology
Market Cap: CN¥6.4b
Engages in medical equipment business in China and internationally.
300358
CN¥9.00
7D
-1.4%
1Y
1.5%
GENOVA
Market Cap: JP¥10.8b
Engages in the medical platform and smart clinic businesses in Japan.
9341
JP¥625.00
7D
1.5%
1Y
-4.0%
Singular Health Group
Market Cap: AU$57.0m
A medical technology company, engages in the development and provision of 3DiCom software medical technology in Australia.
SHG
AU$0.18
7D
-2.7%
1Y
-42.9%
Beijing Airdoc Technology
Market Cap: HK$1.1b
Provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally.
2251
HK$10.40
7D
13.7%
1Y
-19.4%
HBM Holdings
Market Cap: HK$13.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$15.90
7D
5.3%
1Y
27.8%
Telescope Innovations
Market Cap: CA$39.2m
A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.
TELI
CA$0.59
7D
37.2%
1Y
78.8%
Eastwood Bio-Medical Canada
Market Cap: CA$134.3m
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia.
EBM
CA$1.70
7D
-5.6%
1Y
466.7%
CorVel
Market Cap: US$3.5b
Provides workers’ compensation, general and auto liability, and hospital bill auditing and payment integrity solutions.
CRVL
US$70.15
7D
6.7%
1Y
-24.3%
Xlife Sciences
Market Cap: CHF 86.1m
Focuses on the development and commercialization of research projects in the life sciences sector.
XLS
CHF 15.20
7D
-6.7%
1Y
-26.9%
Axe Compute
Market Cap: US$111.2m
Provides access to graphics processing unit and digital asset treasury strategy.
AGPU
US$10.21
7D
23.5%
1Y
-26.8%
Medical Care Technologies
Market Cap: US$389.3k
Operates in the collectibles and memorabilia industry.
MDCE
US$0.00015
7D
-25.0%
1Y
-50.0%
Memphasys
Market Cap: AU$18.5m
Develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.
MEM
AU$0.006
7D
-14.3%
1Y
50.0%
AmCad BioMed
Market Cap: NT$696.7m
Develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan.
4188
NT$11.00
7D
9.5%
1Y
-26.4%
Hi-CRATESLTD
Market Cap: JP¥5.1b
Engages in the research, development, sales, and support of integrated dental electronic medical record systems.
4172
JP¥2,291.00
7D
0.6%
1Y
-1.3%
aetherAI
Market Cap: NT$1.9b
Provides medical image AI solution in Taiwan, Japan, and Germany.
7803
NT$19.60
7D
-0.5%
1Y
-34.7%
GENINUS
Market Cap: ₩78.8b
A bioinformation analysis company, engages in the research and development, manufacture, and sale of genome analysis solutions in South Korea, the United States, and Asia.
A389030
₩2,000.00
7D
-9.7%
1Y
27.2%
Oncotelic Therapeutics
Market Cap: US$17.6m
A clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States.
OTLC
US$0.037
7D
-14.9%
1Y
-26.1%
Poolbeg Pharma
Market Cap: UK£68.7m
A clinical-stage biopharmaceutical company, engages in developing immunotherapy for cancer in the United Kingdom.
POLB
UK£0.088
7D
3.5%
1Y
188.5%
LataMed AI
Market Cap: US$112.3m
A development-stage technology company focused on the research, development, and commercialization of facial recognition technology solutions.
LMED
US$0.48
7D
-14.4%
1Y
556.5%
Light AI
Market Cap: CA$25.1m
A healthcare technology company, focuses on the development of artificial intelligence and machine learning diagnostic digital healthcare solutions.
ALGO
CA$0.20
7D
-14.6%
1Y
-29.3%
Algorae Pharmaceuticals
Market Cap: AU$22.3m
A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.
1AI
AU$0.011
7D
0%
1Y
22.2%
Genetics Generation Advancement
Market Cap: NT$1.1b
Engages in the development and implementation of digital data management systems for gene testing, biological, chemical, and materials information in Taiwan.
4160
NT$39.50
7D
-0.8%
1Y
-25.3%
Resonance Health
Market Cap: AU$28.6m
A healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa.
RHT
AU$0.06
7D
13.2%
1Y
30.4%
TrivarX
Market Cap: AU$17.3m
A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.
TRI
AU$0.015
7D
7.1%
1Y
50.0%
PRISM BioLabLTD
Market Cap: JP¥6.3b
Engages in the research and development of pharmaceuticals using its proprietary drug discovery platform technology, PepMetics Technology.
206A
JP¥170.00
7D
2.4%
1Y
-5.0%
G3 Global Berhad
Market Cap: RM 41.5m
An investment holding company, provides information and communication technology in Malaysia.
G3
RM 0.01
7D
-33.3%
1Y
-50.0%
OneMedNet
Market Cap: US$32.3m
A healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East.
ONMD
US$0.60
7D
-23.2%
1Y
-23.1%
Ever Fortune.AI
Market Cap: NT$5.0b
An cloud-based biomedical platform, provides medical artificial intelligence (AI) solutions and services in China.
6841
NT$53.00
7D
-0.4%
1Y
-24.3%
Medimaging Integrated Solution
Market Cap: NT$2.6b
Engages in the design, manufacture and sale of digital medical imaging diagnostic equipments.
6796
NT$65.30
7D
8.7%
1Y
-11.2%
JLK
Market Cap: ₩118.9b
Provides diagnosis support to the patients with its AI-driven medical platform in South Korea.
A322510
₩4,685.00
7D
-9.9%
1Y
-16.2%
Milton Essex Spólka Akcyjna
Market Cap: zł46.3m
Designs, develops, manufactures, and sells medical devices, instruments, and products in Poland.
MTN
zł0.68
7D
-3.6%
1Y
-6.3%
Identi Healthcare
Market Cap: ₪25.9m
Provides healthcare inventory management systems.
IDNT
₪1.76
7D
0.2%
1Y
-23.3%
NEUROPHET
Market Cap: ₩92.5b
Operates as a neuroscience company, engages in the development of medical artificial intelligence solutions in the field of brain science and diseases.
A380550
₩7,580.00
7D
-14.7%
1Y
-33.3%